Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Science Advances
|
September 30, 2022
COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior
Brian J Schimmoller, Nídia S Trovão, Molly Isbell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 16, 2022
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community
Brian J Schimmoller, Nídia S Trovão, Molly Isbell, et al.
Cancer Letters
|
February 11, 2021
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma
Rachael E Maynard, Brad Poore, Allison R Hanaford, et al.
Cancer Discovery
|
February 19, 2017
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma
Gaylor Boulay, Mary E Awad, Nicolo Riggi, et al.
Nature Genetics
|
December 13, 2016
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Xiaofeng Wang, Ryan S Lee, Burak H Alver, et al.
Acta Neuropathologica
|
November 8, 2013
α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
Soma Sengupta, Shyamal Dilhan Weeraratne, Hongyu Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
Allison R Hanaford, Tenley C Archer, Antoinette Price, et al.
Cancer Cell
|
September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Tenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Nature
|
July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
The Lancet. Oncology
|
May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Science Advances
|
September 30, 2022
COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior
Brian J Schimmoller, Nídia S Trovão, Molly Isbell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 16, 2022
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community
Brian J Schimmoller, Nídia S Trovão, Molly Isbell, et al.
Cancer Letters
|
February 11, 2021
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma
Rachael E Maynard, Brad Poore, Allison R Hanaford, et al.
Cancer Discovery
|
February 19, 2017
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma
Gaylor Boulay, Mary E Awad, Nicolo Riggi, et al.
Nature Genetics
|
December 13, 2016
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Xiaofeng Wang, Ryan S Lee, Burak H Alver, et al.
Acta Neuropathologica
|
November 8, 2013
α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
Soma Sengupta, Shyamal Dilhan Weeraratne, Hongyu Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
Allison R Hanaford, Tenley C Archer, Antoinette Price, et al.
Cancer Cell
|
September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Tenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Nature
|
July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
The Lancet. Oncology
|
May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Page
of 2